The Pathophysiological Impact of HLA Class Ia and HLA-G Expression and Regulatory T Cells in Malignant Melanoma: A Review
Open Access
- 23 November 2016
- journal article
- review article
- Published by Wiley in Journal of Immunology Research
- Vol. 2016, 1-11
Abstract
Malignant melanoma, a very common type of cancer, is a rapidly growing cancer of the skin with an increase in incidence among the Caucasian population. The disease is seen through all age groups and is very common in the younger age groups. Several studies have examined the risk factors and pathophysiological mechanisms of malignant melanoma, which have enlightened our understanding of the development of the disease, but we have still to fully understand the complex immunological interactions. The examination of the interaction between the human leucocyte antigen (HLA) system and prognostic outcome has shown interesting results, and a correlation between the down- or upregulation of these antigens and prognosis has been seen through many different types of cancer. In malignant melanoma, HLA class Ia has been seen to influence the effects of pharmaceutical drug treatment as well as the overall prognosis, and the HLA class Ib and regulatory T cells have been correlated with tumor progression. Although there is still no standardized immunological treatment worldwide, the interaction between the human leucocyte antigen (HLA) system and tumor progression seems to be a promising focus in the way of optimizing the treatment of malignant melanoma.Keywords
This publication has 109 references indexed in Scilit:
- Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon‐mediated rejection genesInternational Journal of Cancer, 2011
- Germline mutations in BAP1 predispose to melanocytic tumorsNature Genetics, 2011
- Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trialThe Lancet Oncology, 2011
- Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease associationCellular and Molecular Life Sciences, 2010
- Multiple Pigmentation Gene Polymorphisms Account for a Substantial Proportion of Risk of Cutaneous Malignant MelanomaJournal of Investigative Dermatology, 2010
- Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomasCancer Immunology, Immunotherapy, 2009
- UVA Generates Pyrimidine Dimers in DNA DirectlyBiophysical Journal, 2009
- MC1R variants, melanoma and red hair color phenotype: A meta‐analysisInternational Journal of Cancer, 2008
- Angiogenesis in MelanomaSeminars in Oncology, 2007
- Mutations of the BRAF gene in human cancerNature, 2002